Naeimzadeh, Y., Tajbakhsh, A., Nemati, M., & Fallahi, J. (2024). Exploring the anti-cancer potential of SGLT2 inhibitors in breast cancer treatment in pre-clinical and clinical studies. European journal of pharmacology, 978, 176803. https://doi.org/10.1016/j.ejphar.2024.176803
Citace podle Chicago (17th ed.)Naeimzadeh, Yasaman, Amir Tajbakhsh, Mahnaz Nemati, a Jafar Fallahi. "Exploring the Anti-cancer Potential of SGLT2 Inhibitors in Breast Cancer Treatment in Pre-clinical and Clinical Studies." European Journal of Pharmacology 978 (2024): 176803. https://doi.org/10.1016/j.ejphar.2024.176803.
Citace podle MLA (9th ed.)Naeimzadeh, Yasaman, et al. "Exploring the Anti-cancer Potential of SGLT2 Inhibitors in Breast Cancer Treatment in Pre-clinical and Clinical Studies." European Journal of Pharmacology, vol. 978, 2024, p. 176803, https://doi.org/10.1016/j.ejphar.2024.176803.